These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 37269117)
1. Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD. Kim BK; Bernstein N; Huang DQ; Tamaki N; Imajo K; Yoneda M; Sutter N; Jung J; Nguyen K; Nguyen L; Le T; Madamba E; Richards L; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R Aliment Pharmacol Ther; 2023 Jul; 58(2):229-237. PubMed ID: 37269117 [TBL] [Abstract][Full Text] [Related]
2. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256 [TBL] [Abstract][Full Text] [Related]
3. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis. Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769 [TBL] [Abstract][Full Text] [Related]
4. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666 [TBL] [Abstract][Full Text] [Related]
5. Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis. Middleton MS; Heba ER; Hooker CA; Bashir MR; Fowler KJ; Sandrasegaran K; Brunt EM; Kleiner DE; Doo E; Van Natta ML; Lavine JE; Neuschwander-Tetri BA; Sanyal A; Loomba R; Sirlin CB; Gastroenterology; 2017 Sep; 153(3):753-761. PubMed ID: 28624576 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Middleton MS; Van Natta ML; Heba ER; Alazraki A; Trout AT; Masand P; Brunt EM; Kleiner DE; Doo E; Tonascia J; Lavine JE; Shen W; Hamilton G; Schwimmer JB; Sirlin CB; Hepatology; 2018 Mar; 67(3):858-872. PubMed ID: 29028128 [TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Schwimmer JB; Middleton MS; Behling C; Newton KP; Awai HI; Paiz MN; Lam J; Hooker JC; Hamilton G; Fontanesi J; Sirlin CB Hepatology; 2015 Jun; 61(6):1887-95. PubMed ID: 25529941 [TBL] [Abstract][Full Text] [Related]
9. Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis. Dennis A; Kelly MD; Fernandes C; Mouchti S; Fallowfield JA; Hirschfield G; Pavlides M; Harrison S; Chakravarthy MV; Banerjee R; Sanyal A Front Endocrinol (Lausanne); 2020; 11():575843. PubMed ID: 33584535 [TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates. Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549 [TBL] [Abstract][Full Text] [Related]
11. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Noureddin M; Lam J; Peterson MR; Middleton M; Hamilton G; Le TA; Bettencourt R; Changchien C; Brenner DA; Sirlin C; Loomba R Hepatology; 2013 Dec; 58(6):1930-40. PubMed ID: 23696515 [TBL] [Abstract][Full Text] [Related]
12. Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. Stine JG; Munaganuru N; Barnard A; Wang JL; Kaulback K; Argo CK; Singh S; Fowler KJ; Sirlin CB; Loomba R Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2274-2283.e5. PubMed ID: 32882428 [TBL] [Abstract][Full Text] [Related]
13. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Caussy C; Alquiraish MH; Nguyen P; Hernandez C; Cepin S; Fortney LE; Ajmera V; Bettencourt R; Collier S; Hooker J; Sy E; Rizo E; Richards L; Sirlin CB; Loomba R Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868 [TBL] [Abstract][Full Text] [Related]
15. Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study. Yazdani L; Rafati I; Gesnik M; Nicolet F; Chayer B; Gilbert G; Volniansky A; Olivié D; Giard JM; Sebastiani G; Nguyen BN; Tang A; Cloutier G Ultrasound Med Biol; 2023 Oct; 49(10):2264-2272. PubMed ID: 37482477 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Gu J; Liu S; Du S; Zhang Q; Xiao J; Dong Q; Xin Y Eur Radiol; 2019 Jul; 29(7):3564-3573. PubMed ID: 30899974 [TBL] [Abstract][Full Text] [Related]
17. Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH. Loomba R; Neuschwander-Tetri BA; Sanyal A; Chalasani N; Diehl AM; Terrault N; Kowdley K; Dasarathy S; Kleiner D; Behling C; Lavine J; Van Natta M; Middleton M; Tonascia J; Sirlin C; Hepatology; 2020 Oct; 72(4):1219-1229. PubMed ID: 31965579 [TBL] [Abstract][Full Text] [Related]
18. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591 [TBL] [Abstract][Full Text] [Related]
19. Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity. Wibulpolprasert P; Subpinyo B; Chirnaksorn S; Shantavasinkul PC; Putadechakum S; Phongkitkarun S; Sritara C; Angkathunyakul N; Sumritpradit P Sci Rep; 2024 Mar; 14(1):6895. PubMed ID: 38519637 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software. Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]